We change lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1989
Size (employees)
5,250 (est)+21%
Website
resmed.com
ResMed was founded in 1989 and is headquartered in San Diego, US

ResMed Office Locations

ResMed has offices in San Diego, Kontich, Espoo, Moissy-Cramayel and in 23 other locations
San Diego, US (HQ)
9001 Spectrum Center Blvd
Rochester, US
1200 Brooks Ave
Singapore, SG
8 Loyang Cres
Guangzhou Shi, CN
Jian She Liu Ma Lu
Shanghai, CN
Wagas ( Shan Xi Bei Lu )
Beijing, CN
24 Dong San Huan Zhong Lu
Bella Vista, AU
1 Elizabeth Macarthur Dr
London, GB
8 Wimpole St
Basel, CH
40 Viaduktstrasse
Stockholm, SE
17 Jan Stenbecks Torg
1 Fjordveien
Hoofddorp, NL
17 27 Siriusdreef
Donnybrook, IE
Belfield Office Park Beech Hill Rd
Marousi, GR
90 Leof. Kifisias
Bremen, DE
40 Haferwende
Planegg, DE
16 Fraunhoferstraße
Moissy Cramayel, FR
240 Rue De La Motte
Espoo, FI
3 Hevosenkenkä
Kontich, BE
50 Grote Steenweg

ResMed Data and Metrics

ResMed Financial Metrics

ResMed's revenue was reported to be $1.8 b in FY, 2016 which is a 10% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

1.8 b

Revenue growth (FY, 2015 - FY, 2016), %

10%

Gross profit (FY, 2016)

1.1 b

Gross profit margin (FY, 2016), %

58%

Net income (FY, 2016)

352.4 m

EBIT (FY, 2016)

429 m

Market capitalization (26-May-2017)

9.9 b

Closing share price (26-May-2017)

70.1

Cash (30-Jun-2016)

731.4 m
ResMed's current market capitalization is $9.9 b.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Revenue

1.6 b1.7 b1.8 b

Revenue growth, %

8%10%

Cost of goods sold

667.5 m772.2 m

Gross profit

1 b1.1 b

Gross profit Margin, %

60%58%

Operating expense total

602.2 m637.5 m

EBIT

409.2 m429 m

EBIT margin, %

24%23%

Interest expense

5.8 m11.2 m

Interest income

26.2 m

Pre tax profit

435.9 m439.6 m

Income tax expense

83 m87.2 m

Net Income

345.3 m352.9 m352.4 m
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Cash

905.7 m717.2 m731.4 m

Accounts Receivable

Inventories

165.4 m246.9 m224.5 m

Current Assets

1.6 b1.4 b1.4 b

PP&E

434.3 m387.8 m384.3 m

Goodwill

1.1 b

Total Assets

2.4 b2.2 b3.3 b

Accounts Payable

85.4 m81.1 m92.6 m

Total Debt

300.8 m300.6 m

Current Liabilities

269.6 m267.3 m638.6 m

Non-Current Liabilities

333.2 m329.7 m925.6 m

Total Liabilities

602.7 m597 m1.6 b

Additional Paid-in Capital

1.1 b1.2 b1.3 b

Retained Earnings

1.8 b2 b2.2 b

Total Equity

1.8 b1.6 b1.7 b

Debt to Equity Ratio

0.2 x0.2 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.3 x1.4 x1.9 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

345.3 m352.9 m352.4 m

Depreciation and Amortization

73.5 m73.1 m86.8 m

Accounts Receivable

(35 m)(28 m)(27 m)

Inventories

Accounts Payable

Cash From Operating Activities

391.3 m383.2 m547.9 m

Purchases of PP&E

(72.7 m)(62.5 m)(58.5 m)

Cash From Investing Activities

(95 m)(143.1 m)(1.1 b)

Dividends Paid

(141.5 m)(157.3 m)(168.1 m)

Cash From Financing Activities

(297.3 m)(255.8 m)612.6 m

Interest Paid

6.1 m5.8 m11.2 m

Income Taxes Paid

90.2 m48.5 m69 m
Numbers are in $, USDY, 2016

Revenue/Employee

423.7 k

Financial Leverage

1.9 x

ResMed Market Value History

ResMed Median Salaries

Source: 31 public H-1B filings from ResMed

ResMed Online and Social Media Presence

ResMed Company Life and Culture

You may also be interested in